We are live on ! Find out more
SEF icon

ProShares Short Financials

5 hedge funds and large institutions have $722K invested in ProShares Short Financials in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

4.92% less ownership

Funds ownership: 12.65%7.73% (-4.9%)

38% less capital invested

Capital invested by funds: $1.17M → $722K (-$450K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

SEF Hedge Fund Activity: Q2 2025 in Review

5 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in ProShares Short Financials (SEF) for Q2 2025, worth a combined $722K — down 38% from $1.17M a quarter earlier.

Fund positioning in SEF was balanced in Q2 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was CPR Investments, opening a new position worth an estimated $214K. The largest seller was Tower Research Capital (TRC), cutting an estimated $588K.

  • 5 institutional investors held ProShares Short Financials (SEF) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $722K of ProShares Short Financials stock for Q2 2025, down 38% quarter-over-quarter.
  • 1 fund opened new ProShares Short Financials positions in Q2 2025 and 1 closed out, a net change of 0 holders.
  • The largest ProShares Short Financials buyer in Q2 2025 was CPR Investments, an estimated $214K added.
  • The largest ProShares Short Financials seller in Q2 2025 was Tower Research Capital (TRC), an estimated $588K sold.

Based on aggregated 13F filings for Q2 2025.